Anatomy of a Drug Manufacturing Plant (Last in a Three Part Series Examining the Financial Impact of New Plant Construction)

SUGAR LAND--July 28, 2016--Reported by Annette Kreuger for Industrial Information Resources Sugar Land, Texas)--Once construction has wrapped up and the validation process for a new pharmaceutical or biotech (pharma-bio) plant is complete, it is time to begin production. Not only does an operational plant manufacture drug products that improve the public's physical health, but it also sets off a ripple effect that is beneficial to the financial well-being of the host community, county and state.

Within this article: Economic impact of the Novo Nordisk insulin plant in North Carolina.